Jump to any asset
849 assets, updated daily
As of October 11, 2026, Danaher Corp. (DHR) trades at $219.81. CleaRank Financial AI rates it Buy with a fair value of $233.00, 6.0% above the current price. Wall Street's consensus target is $233.00 across 25 analysts. RSI at 54 is in neutral territory, and the price is above its 50-day average of $211.05.
Danaher Corp. (DHR)
Danaher Corp. NYSE
$219.81
2.350 (1.08%)
At close: Oct 9, 4:00 PM EDT
AI Analyst Consensus
77 / 100
Danaher Corp. (DHR) is trading at $219.81, showing a neutral RSI of 54.1 and trading above its 50-day and 200-day moving averages ($211.05 and $201.44). The company has a consensus rating of Buy, supported by 25 analysts with a median price target of $233.00, implying a 6.0% upside. Recent earnings have shown consistent beats, with the latest quarter to September 2026 reporting EPS of $4.40 against an estimate of $4.08, a 7.84% surprise, though the stock saw a 4.42% decline post-earnings. Forward estimates are positive, with revenue growth projected at 11.00% for the next quarter and 7.00% for the current year. Despite the positive outlook, a significant concern is the heavy insider selling, with over $507.5 million in sales reported recently, indicating a net seller position. While the company's fundamentals, including a 15.95% profit margin and 7.61% return on equity, are solid and compare favorably to sector averages in terms of profit margin, the substantial insider dispositions warrant close observation. The dividend yield stands at approximately 0.69%.
DHR Price Analysis
Market Metrics
Open
$216.91
Day Range
$216.51 to $220.86
Prev Close
$217.46
Volume
3.93M
52-Week Range
$160.93 to $242.80
Market Cap
$154.52B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Trading at a significant premium to sector peers (+22%), suggesting market expectations for superior growth or market position.
DHR Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 3 quarters, DHR beat estimates 2 times. However, the stock fell 2 times the next day. This suggests positive news is often "priced in" or investors are selling the news.
DHR Analysis
Company's Health
4/5
12-Month Analyst Target
+6.00% Upside
Median of 25 analysts (12-month)
$233.00
AI Technical Analysis
Danaher Corp. (DHR) is currently trading above its 50-day and 200-day moving averages ($211.05 and $201.44), indicating a generally positive trend. The RSI is at 54.1, suggesting neutral momentum, neither overbought nor oversold. The MACD at 2.49 also points to a lack of strong directional conviction. Key support levels are indicated by the moving averages, with the 50-day SMA at $211.05 and the 200-day SMA at $201.44. Resistance levels are less clearly defined by the current technicals, but the current price of $219.81 is above the 20-day EMA of $216.81. Volume on the latest trading day was 3.93 million, slightly below the average of 4.29 million, suggesting moderate investor interest.
ProTips
- Monitor insider transaction activity closely; the recent heavy selling warrants caution despite the 'Buy' consensus.
- Given the premium valuation, consider position sizing carefully and look for confirmation of continued revenue growth exceeding 7% year-over-year.
- The company's strong profit margins and consistent earnings performance suggest operational efficiency, but the elevated P/E ratio means any slowdown could be punished.
Key Catalysts
Bullish
Strong Analyst Consensus and Price Targets
25 analysts maintain a Buy rating, with a median price target of $233.00, indicating confidence in future performance and potential upside.
Source: Wall Street AnalystsBullish
Consistent Earnings Beats
Danaher Corp. has a track record of exceeding EPS estimates, most recently by 7.84% for the quarter ending September 2026, demonstrating operational execution.
Source: Earnings ReportsBearish
Heavy Insider Selling
Insiders have sold over $507.5 million in stock recently, indicating a net seller position and potentially signaling management concerns despite positive analyst ratings.
Source: Insider TransactionsBearish
Elevated Valuation Metrics
The company's P/E ratio of 39.04 and P/S ratio of 6.13 are above sector medians, suggesting the stock may be overvalued and susceptible to pullbacks.
Source: Fundamental AnalysisMarket Outlook
Danaher Corp. (DHR) is expected to maintain its positive trajectory over the next 6-12 months, driven by strong analyst conviction and projected revenue growth. The median analyst target price of $233.00 suggests a modest 6.0% upside from the current price of $219.81. The company's strong profit margins and consistent earnings beats provide a solid foundation for this outlook. Potential catalysts for upside include continued innovation within its diagnostics and research segments and successful integration of any strategic acquisitions. Conversely, significant insider selling and a premium valuation present downside risks. Any failure to meet elevated market expectations or increased competitive pressure could lead to a re-rating of the stock. The company's dividend yield of 0.69% offers a small income component.
Key Statistics
| Market Cap | 154.52B |
|---|---|
| P/E Ratio | 39.04 |
| EPS (TTM) | 5.61 |
| Dividend Yield | 0.69% |
| 52 Week High | 242.80 |
| 52 Week Low | 160.93 |
Danaher Corp. (DHR) exhibits a P/E ratio of 39.04, which is above the sector median of 31.9, suggesting a premium valuation. Its Price-to-Sales ratio is 6.13, also higher than the sector median of 3.7. The company's profit margin of 15.95% and return on equity of 7.61% are strong, with the profit margin significantly exceeding the sector median of 6.9%. The debt-to-equity ratio stands at 0.53, aligning with the sector average. Forward-looking estimates show revenue growth projected at 7.00% for the current year and 8.00% for the next year, with a 5-year average annual growth rate of 10.18%. While the valuation appears somewhat stretched compared to sector averages, the company's strong profitability and consistent revenue growth support its current trading levels.
Earnings & Growth Analysis
Danaher Corp. (DHR) has demonstrated a pattern of earnings beats in recent quarters. The most recent report for the quarter ending September 2026 showed an EPS of $4.40, exceeding the estimate of $4.08 by 7.84%. However, this beat was accompanied by a 4.42% stock price decline. Prior quarters also showed positive surprises, such as the quarter ending June 2026 with an EPS beat of 6.36%. The company's forward EPS estimates are positive, with the current year projected at $8.51 and next year at $9.30.
Key Risks
The primary risk for Danaher Corp. (DHR) is the significant insider selling, with over $507.5 million in dispositions, signaling potential concerns from management despite a 'Buy' consensus. The company's valuation also appears elevated, trading at a premium P/E ratio compared to its healthcare sector peers. Additionally, the recent post-earnings stock price decline following an EPS beat suggests that market expectations may be very high, creating a risk of disappointment if future results do not exceed these expectations.
Technical Indicators
| RSI (14) | 54.10 |
|---|---|
| MACD | 2.49 |
| SMA 50 | 211.05 |
| SMA 200 | 201.44 |
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($211.05) above the 200-day SMA ($201.44), price action is firmly bullish above key moving averages.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.41
Moderate correlation
Nasdaq 100 (QQQ)
+0.29
Weak correlation
Bitcoin (BTC)
-0.07
Weak correlation
Gold (XAU)
-0.01
Weak correlation
Check Custom Correlation
How does any other asset move with DHR? One year of daily closes, Pearson correlation.
Try
DHR Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Long entry pick an entry style
Conservative
$215.41
2% below current price (Pullback entry)
Lower risk, wait for pullback
Aggressive
$219.81
Buy at current price
Higher risk, immediate entry
Risk Management
STOP LOSS
$208.93
MAX LOSS
-3.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (54.1) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$226.18
+5% (Conservative)
+2.9% (Aggressive)
TARGET 2
$236.96
+10% (Conservative)
+7.8% (Aggressive)
TARGET 3
$247.73
+15% (Conservative)
+12.7% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for DHR is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on October 11, 2026.Growth of $10,000
A $10,000 investment in DHR in October 2016 would be worth about $32,479 today, compared with about $36,479 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in DHR today could grow to about $25,474 by 2036 in the base case, with a bull case near $73,827 and a bear case around $8,789. Projections are statistical simulations, not guarantees.
DHR Stock Price Prediction: 2030
CleaRank's simulation projects a price near $320 for DHR by 2030 in the base case, from $220 today (1.5x over 4 years). The downside path ends near $163. These are outcomes of a Monte Carlo simulation run on DHR's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $172 | $241 | $338 |
| 2028 | $165 | $265 | $427 |
| 2029 | $162 | $291 | $521 |
| 2030 | $163 | $320 | $626 |
| 2031 | $165 | $351 | $744 |
| 2032 | $169 | $385 | $878 |
| 2033 | $174 | $423 | $1,030 |
| 2034 | $179 | $464 | $1,203 |
| 2035 | $186 | $510 | $1,399 |
| 2036 | $193 | $560 | $1,623 |
Method: 10,000 simulated price paths using DHR's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
DHR Insider Trading Analysis
Bought
None
No open-market buys
Sold
$507.5M
13 Transactions
Insiders
25
Active Traders
Avg Transaction
$39.0M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2021 | RALES MITCHELL P
Officer and Director
|
Sell | 1.2M | $377.9M |
| May 12, 2025 | RALES STEVEN M
Chairman of the Board
|
Sell | 1.3M | $245.9M |
| Oct 31, 2025 | RALES MITCHELL P
Officer and Director
|
Sell | 600.0K | $129.6M |
| Nov 12, 2025 | RALES MITCHELL P
Officer and Director
|
Sell | 437.0K | $95.6M |
| Jul 24, 2020 | JOYCE THOMAS PATRICK JR
Chief Executive Officer
|
Sell | 181.4K | $35.2M |
| May 24, 2019 | DANIEL WILLIAM K II
Officer
|
Sell | 164.2K | $21.7M |
| Jan 31, 2020 | JOYCE THOMAS PATRICK JR
Chief Executive Officer
|
Sell | 132.5K | $21.5M |
| Jul 27, 2020 | COMAS DANIEL L
Officer
|
Sell | 100.0K | $19.5M |
| Aug 31, 2020 | LALOR ANGELA S
Officer
|
Sell | 77.9K | $16.0M |
| Feb 3, 2020 | COMAS DANIEL L
Officer
|
Sell | 82.5K | $13.3M |
Page 1 of 1
Frequently Asked Questions
What is Danaher Corp.'s stock price forecast for 2030?
Danaher Corp.'s (DHR) stock price forecast for 2030, based on Monte Carlo simulations, projects a base case of $319.51, with a downside scenario of $163.01 and an upside scenario of $626.26. These figures represent simulation outcomes, not guaranteed price targets.
Is Danaher Corp. stock a buy right now?
Danaher Corp. (DHR) is currently rated a Buy by Wall Street analysts, with a median price target of $233.00, suggesting a 6.0% upside from its current price of $219.81. The consensus score is 77 out of 100.
How has Danaher Corp. performed in recent earnings reports?
Danaher Corp. (DHR) has consistently beaten earnings estimates, most recently reporting an EPS of $4.40 for the quarter ending September 2026, surpassing expectations by 7.84%. However, the stock experienced a price decline following this report.
What are the key risks facing Danaher Corp. shareholders?
Key risks for Danaher Corp. (DHR) include significant insider selling totaling over $507.5 million, an elevated P/E ratio compared to sector peers, and the potential for market disappointment if future earnings do not exceed high expectations.
How does Danaher Corp.'s valuation compare to its peers?
Danaher Corp. (DHR) trades at a P/E ratio of 39.04 and a Price-to-Sales ratio of 6.13, both of which are higher than the sector medians of 31.9 and 3.7, respectively, indicating a premium valuation.
What is the outlook for Danaher Corp.'s revenue growth?
Danaher Corp. (DHR) is projected to achieve revenue growth of 11.00% in the next quarter and 7.00% for the current year. The company's 5-year average annual revenue growth rate has been approximately 12.33%.
What is the dividend yield for Danaher Corp. stock?
Danaher Corp. (DHR) offers a dividend yield of approximately 0.69%, with a current dividend rate of $1.52 per share.